다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Corcept Therapeutics Inc (CORT)
Corcept Therapeutics Inc (CORT) 뉴스

CORT

Corcept Therapeutics (CORT)

Corcept Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CORT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/07	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/06	10:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/04	03:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/04	03:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/04	02:05	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/03	21:00	GlobeNewswire Inc.	Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:47	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:46	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:45	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:44	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:43	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:41	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:40	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:39	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:38	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:38	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:38	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:CORT	Corcept Therapeutics Inc
2024/06/01	05:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/31	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/31	09:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/29	08:53	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/29	02:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/29	02:14	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/28	21:00	GlobeNewswire Inc.	Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing’s Syndrome)	NASDAQ:CORT	Corcept Therapeutics Inc
2024/05/24	05:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CORT	Corcept Therapeutics Inc

검색 관련기사 보기:NASDAQ:CORT

1 2 3 4 5 6 7 8 9 10 다음 >>

Deutsche Telekom (QX)

Bank of America

BNP Paribas (QX)

Gold vs US Dollar

Invesco QQQ Trust Series 1

Health Care Select Sector

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관